Why Repros Therapeutics Inc. Stock Rocketed Higher

Fool.com Headlines http://ift.tt/1wJphBp Repros Therapeutics' stock is among today's top gainers after the company's lead experimental drug goes head-to-head against a rival and easily comes out on top.